Probiotics and Antimicrobial Peptides: The Creatures' and Substances' Future in the Twenty-First Century: An Opinion Letter

Probiotics and Antimicrobial Proteins

Volumn 6, Issue 2, 2014, Pages 69-72

  Chikindas, Michael L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; CHOLESTEROL; HYDROGEN PEROXIDE; LACTIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; SPERMICIDAL AGENT; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; AQUACULTURE; BACTERIUM; CANCER PREVENTION; DIET SUPPLEMENTATION; EDITORIAL; FOOD PRESERVATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOMODULATION; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; DRUG THERAPY; METABOLISM; STANDARDS; TRENDS;

ANTI-INFECTIVE AGENTS; DRUG THERAPY; HUMANS; LACTOBACILLUS; PEPTIDES; PROBIOTICS;

EID: 84901306687     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-014-9161-7     Document Type: Editorial

References (33)

1. Anonymous (2010) Global probiotic market to grow: analyst. FLEXNEWS. 27 Sept 2010.
2. Lahtinen SJ, Boyle RJ, Margolles A et al (2009) Safety assessment of probiotics. Prebiotics and probiotics science and technology. Springer Science & Business Media, LLC, New York, pp 1193-1235.
3. Besselink MG, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371(9613): 651-659.
4. California Dairy Research Foundation. Commercial strains sold as probiotics. http://cdrf. org/home/checkoff-investments/usprobiotics/products-with-probiotics/#commercial. Accessed 24 April 2014.
5. Guidelines for the Evaluation of Probiotics in Food: Joint FAO/WHO Working Group meeting, London Ontario, Canada, 30 April-1 May 2002. http://www. who. int/foodsafety/fs_management/en/probiotic_guidelines. pdf. Accessed 24 April 2014.
6. Sanders MA, Heimbach JT, Pot B et al (2011) Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2: 127-133. doi: 10. 4161/gmic. 2. 3. 16174.
7. Hoffman DE, Fraser CM, Palumbo F et al (2013) Final Report Federal Regulation of Probiotics: An Analysis of the Existing Regulatory Framework and Recommendations for Alternative Frameworks NIH Grant Number: 5R01HG005171-02. http://www. law. umaryland. edu/programs/health/events/probiotics/documents/FinalWhitePaper. pdf. Accessed 24 April 2014.
8. Youghurt and Live Fermented Milks Association-YLFA International (2012) Probiotics and the EU nutrition & health claims regulation: Finding a workable solution. http://ylfa. org/images/file/Workable%20solution%20for%20probiotics-2012. pdf. Accessed 24 April 2014.
9. Katan MB (2012) Why the European food safety authority was right to reject health claims for probiotics. Benef Microbes 3: 85-89. doi: 10. 3920/BM2012. 0008.
10. Hoffmann DE (2012) Health claim regulation of probiotics in the USA and the EU: is there a middle way? Benef Microbes 4: 109-115. doi: 10. 3920/BM2012. 0033.
11. The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214. doi: 10. 1038/nature11234.
12. Sung V, Hiscock H, Tang MLK et al (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348: g2107. doi: 10. 1136/bmj. g2107.
13. Yamashiro Y, Nagata S (2010) Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy. Benef Microbes 1: 357-365. doi: 10. 3920/BM2010. 0035.
14. Leyer GJ, Li S, Mubasher ME et al (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124: e172-e179. doi: 10. 1542/peds. 2008-2666.
15. Gutierrez-Castrellon P, Lopez-Velazquez G, Diaz-Garcia L et al (2014) Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 133: e904-e909. doi: 10. 1542/peds. 2013-0652.
16. Kenny M, Smidt H, Mengheri E et al (2011) Probiotics: do they have a role in the pig industry? Animal 5: 462-470. doi: 10. 1017/S175173111000193X.
17. Cruz PM, Ibáñez AL, Monroy Hermosillo OA et al (2012) Use of probiotics in aquacultures. ISRN Microbiol. Article ID 916845. doi: 10. 5402/2012/916845.
18. Lutful Kabir SM (2009) The role of probiotics in the poultry industry. Int J Mol Sci 10: 3531-3546. doi: 10. 3390/ijms10083531.
19. Schnorr SL, Candela M, Rampelli S et al (2014) Gut microbiome of the Hadza hunter-gatherers. Nat Commun 5: 3654. doi: 10. 1038/ncomms4654.
20. Aroutcheva A, Gariti D, Simon M et al (2001) Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 185: 375-379. doi: 10. 1067/mob. 2001. 115867.
21. Gálvez A, Abriouel H, López RL et al (2007) Bacteriocin-based strategies for food biopreservation. Int J Food Microbiol 120: 51-70. doi: 10. 1016/j. ijfoodmicro. 2007. 06. 001.
22. Dobson A, Cotter PD, Ross RP et al (2011) Bacteriocin production: a probiotic trait? Appl Environ Microbiol 78: 1-6. doi: 10. 1128/AEM. 05576-11.
23. Dicks LMT, Heunis TDJ, van Staden DA, Brand A et al (2011) Medical and personal care applications of bacteriocins produced by lactic acid bacteria. In: Drider D, Rebuffat S (Eds), Prokaryotic antimicrobial peptides. Springer ISBN 978-1-4419-7691-8. doi: 10. 1007/978-1-4419-7692.
24. Martin-Visscher LA, Yoganathan S, Sit CS et al (2011) The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram-negative bacteria in combination with EDTA treatment. FEMS Microbiol Lett 317: 152-159. doi: 10. 1111/j. 1574-6968. 2011. 02223. x.
25. Joseph B, Dhas B, Hena V et al (2013) Bacteriocin from Bacillus subtilis as a novel drug against diabetic foot ulcer bacterial pathogens. Asian Pac J Trop Biomed 3: 942-946. doi: 10. 1016/S2221-1691(13)60183-5.
26. Acuña L, Picariello G, Sesma F et al (2012) A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria. FEBS Open Bio 2: 12-19. doi: 10. 1016/j. fob. 2012. 01. 002.
27. Torres NI, Sutyak Noll K, Xu S et al (2013) Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob Proteins 5: 26-36. doi: 10. 1007/s12602-012-9123-x.
28. Naghmouchi K, Belguesmia Y, Baah J et al (2011) Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli. Res Microbiol 162: 99-107. doi: 10. 1016/j. resmic. 2010. 09. 014.
29. Draper LA, Cotter PD, Hill C et al (2013) The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. BMC Microbiol 13: 212. doi: 10. 1186/1471-2180-13-212.
30. Hammami R, Zouhir A, Le Lay C et al (2010) BACTIBASE second release: a database and tool platform for bacteriocin characterization. BMC Microbiol 10: 22. doi: 10. 1186/1471-2180-10-22.
31. Arthur TD, Cavera VL, Chikindas ML (2014) On bacteriocin delivery systems and potential applications. Future Microbiol 9: 235-248. doi: 10. 2217/fmb. 13. 148.
32. Cotter PD, Ross RP, Hill C (2013) Bacteriocins: a viable alternative to antibiotics? Nat Rev Microbiol 11: 95-105. doi: 10. 1038/nrmicro2937.
33. Cleveland J, Montville TJ, Nes IF et al (2001) Bacteriocins: safe natural antimicrobials for food preservation. Int J Food Microbiol 71: 1-20. doi: 10. 1016/S0168-1605(01)00560-8.